Data / Research funding / Endocannabinoid System Research

Endocannabinoid System Research: 258 NIH awards ($253.6M) to 113 organizations

Name: NIH and NSF awards on Endocannabinoid System Research
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

258 NIH awards ($253.6M) in the NIH spending category Endocannabinoid System Research, to 113 organizations, read 2026-11-04. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards on Endocannabinoid System Research Watch Endocannabinoid System Research

Topic: NIH spending category

Awards

258 awards in the window.

Award	Agency	Institute or division	Fiscal year	Amount in window	Start	End	Principal investigator	Source
Rocky Mountain Cannabis Research Center	NIH	National Institute on Drug Abuse	2023 to 2025	$8,380,548	September 1, 2023	June 30, 2028	HUTCHISON, KENT E.	reporter.nih.gov
CB1 Neutral Antagonists for Alcohol Use Disorder	NIH	National Institute on Alcohol Abuse and Alcoholism	2021 to 2024	$5,965,782	September 20, 2020	August 31, 2025	MAKRIYANNIS, ALEXANDROS	reporter.nih.gov
Translational Studies of Cannabis Administration, Cognition, and the Endocannabinoid System in HIV	NIH	National Institute on Drug Abuse	2021 to 2025	$4,324,439	May 1, 2021	July 31, 2026	MINASSIAN, ARPI	reporter.nih.gov
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV	NIH	National Institute on Drug Abuse	2022 to 2025	$3,584,464	June 15, 2022	March 31, 2027	ELLIS, RONALD J.	reporter.nih.gov
Risk and Resilience in Urban Black American Acute Trauma Survivors	NIH	National Institute of Mental Health	2021 to 2025	$3,579,657	September 16, 2021	July 31, 2027	LARSON, CHRISTINE L	reporter.nih.gov
Origin of Cortical Species-specific Distinctions	NIH	National Institute on Drug Abuse	2021 to 2025	$3,571,176	April 1, 2025	March 31, 2030	RAKIC, PASKO	reporter.nih.gov
Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease	NIH	National Institute on Aging	2021 to 2024	$3,503,395	June 1, 2020	March 31, 2026	RIZZO, STACEY J	reporter.nih.gov
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection	NIH	National Institute on Drug Abuse	2021 to 2024	$3,267,557	September 30, 2020	June 30, 2026	MOHAN, MAHESH	reporter.nih.gov
Prenatal Cannabis Exposure (PreCE) and Immune-Endocannabinoid Pathways to Development of Offspring Brain and Behavior up to Age 6	NIH	National Institute on Drug Abuse	2021 to 2025	$3,245,617	April 1, 2019	March 31, 2030	ROGERS, CYNTHIA ELISE	reporter.nih.gov
Modulation of pain mechanisms by cannabis-derived phytochemicals.	NIH	National Center for Complementary & Integrative Health	2021 to 2025	$3,150,461	December 1, 2020	November 30, 2026	SETO, TODD B	reporter.nih.gov
Cannabis and Nicotine Co-Use Influences on Protracted Development of Neural Structure and Function	NIH	National Institute on Drug Abuse	2021 to 2025	$3,058,239	August 15, 2021	May 31, 2027	JACOBUS, JOANNA	reporter.nih.gov
The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy	NIH	National Institute on Drug Abuse	2021 to 2025	$2,992,059	April 1, 2021	December 31, 2025	PERSIDSKY, YURI	reporter.nih.gov
RBP2 Biology and Pathobiology	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$2,929,487	June 15, 2019	May 31, 2027	BLANER, WILLIAM S	reporter.nih.gov
Investigating the effect of oral microbiome on cognition in HIV-infected chronic cannabis users	NIH	National Institute on Drug Abuse	2022 to 2025	$2,858,390	September 30, 2022	July 31, 2027	FITTING, SYLVIA	reporter.nih.gov
Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms	NIH	National Institute on Drug Abuse	2021 to 2025	$2,790,999	May 1, 2021	February 28, 2027	BRUEHL, STEPHEN	reporter.nih.gov
Cannabis use following trauma exposure: An observational study of the impact of acute stress and fear response on cannabis outcomes	NIH	National Institute on Drug Abuse	2022 to 2025	$2,737,372	August 15, 2022	May 31, 2027	NUGENT, NICOLE R	reporter.nih.gov
Postsynaptic roles of ankyrins	NIH	National Institute of Mental Health	2022 to 2025	$2,559,284	March 1, 2015	March 31, 2027	PENZES, PETER	reporter.nih.gov
Local Circuit Control of Rapid Plasticity and Tunable Ensemble Formation in the Hippocampus	NIH	National Institute of Neurological Disorders and Stroke	2023	$2,554,313	September 1, 2023	August 31, 2026	LOSONCZY, ATTILA	reporter.nih.gov
Cannabis, inflammation, and the brain in persons with HIV	NIH	National Institute on Drug Abuse	2021 to 2024	$2,527,684	September 30, 2020	June 30, 2025	IUDICELLO, JENNIFER E	reporter.nih.gov
Fetal cerebral arteries and prenatal alcohol exposure	NIH	National Institute on Alcohol Abuse and Alcoholism	2022 to 2025	$2,492,106	March 15, 2022	January 31, 2027	BUKIYA, ANNA	reporter.nih.gov
Synaptic transport of endocannabinoids in the brain	NIH	National Institute of Mental Health	2021 to 2024	$2,349,284	April 1, 2021	February 28, 2026	HAJ-DAHMANE, SAMIR	reporter.nih.gov
Cannabinoid Receptors and Associated Proteins-Renewal	NIH	National Institute on Drug Abuse	2021 to 2025	$2,347,872	August 15, 2017	March 31, 2028	HOWLETT, ALLYN C	reporter.nih.gov
Quorum Sensing Regulation of EHEC Virulence Genes	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2025	$2,346,135	January 1, 2023	December 31, 2027	SPERANDIO, VANESSA	reporter.nih.gov
Endogenous Cannabinoid Control of Reward Substrates	NIH	National Institute on Drug Abuse	2021 to 2025	$2,320,372	March 1, 2008	April 30, 2027	CHEER, JOSEPH F	reporter.nih.gov
Silencing of astrocytic MAGL as a therapy for Alzheimer’s disease	NIH	National Institute on Aging	2023	$2,278,287	April 15, 2023	March 31, 2026	CHEN, CHU	reporter.nih.gov
Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model	NIH	National Institute on Drug Abuse	2021 to 2023	$2,266,058	September 30, 2020	June 30, 2025	WILLIAMS, DIONNA WHITNEY	reporter.nih.gov
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation	NIH	National Institute of Mental Health	2022 to 2025	$2,237,917	June 15, 2016	March 31, 2026	PATEL, SACHIN	reporter.nih.gov
Exercise facilitation of adolescent fear extinction, frontolimbic circuitry, and endocannabinoids	NIH	National Institute of Mental Health	2023 to 2025	$2,230,303	July 15, 2023	April 30, 2028	MARUSAK, HILARY	reporter.nih.gov
Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling	NIH	National Cancer Institute	2021 to 2025	$2,219,816	August 5, 2021	July 31, 2026	KHASABOV, SERGEY G	reporter.nih.gov
Endocannabinoid Targeting for Opioid Induced Respiratory Depression	NIH	National Institute on Drug Abuse	2022 to 2025	$2,190,554	July 1, 2022	June 30, 2027	MILNES, TALLY MARIE	reporter.nih.gov
Endocannabinoids in neurodegenerative diseases	NIH	National Institute of Neurological Disorders and Stroke	2023	$2,151,868	June 15, 2012	April 30, 2026	CHEN, CHU	reporter.nih.gov
Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial	NIH	National Institute on Aging	2023 to 2025	$2,143,253	July 1, 2023	June 30, 2028	HUTCHISON, KENT E.	reporter.nih.gov
Regulation of synaptic plasticity by BDNF-endocannabinoid interactions	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2025	$2,110,192	December 1, 2019	November 30, 2026	LEVINE, ERIC S	reporter.nih.gov
Sleep-dependent synaptic homeostasis in Alzheimer's disease	NIH	National Institute on Aging	2021	$2,106,477	April 15, 2021	March 31, 2024	DIERING, GRAHAM HUGH	reporter.nih.gov
Mechanistic Inflammatory Pathways in Graft Versus Host Disease	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$2,100,486	August 1, 2020	May 31, 2026	DROBYSKI, WILLIAM R.	reporter.nih.gov
Endocannabinoid-Based Treatment for the Neurologic Niemann-Pick Diseases	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2022 to 2025	$2,087,153	September 9, 2022	August 31, 2027	SCHUCHMAN, EDWARD H.	reporter.nih.gov
Role of endocannabinoid signaling in a preference/aversion circuitry	NIH	National Institute on Drug Abuse	2022 to 2025	$2,063,766	April 15, 2022	January 31, 2027	GUO, SU	reporter.nih.gov
Modulating Signaling Endocannabinoids and Fatty Acid Amides	NIH	National Institute on Drug Abuse	2021 to 2025	$2,053,125	December 1, 2021	November 30, 2026	BOGER, DALE L	reporter.nih.gov
Novel fluorescent sensors for imaging neuromodulation	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$2,001,408	August 15, 2019	May 31, 2024	DAN, YANG	reporter.nih.gov
Therapeutic antibodies for treating liver fibrosis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2023	$1,999,998	June 1, 2020	July 31, 2025	SCHWIMMER, LAUREN JENNIFER	reporter.nih.gov
Modeling the effects of chronic marijuana use on neuroinflammation and HIV-related neuronal injury	NIH	National Institute on Drug Abuse	2021 to 2022	$1,976,642	September 30, 2020	June 30, 2023	MEADE, CHRISTINA S	reporter.nih.gov
Allosteric Modulation of the CB1 Receptor	NIH	National Institute on Alcohol Abuse and Alcoholism	2023 to 2025	$1,940,546	April 1, 2023	March 31, 2028	ZHANG, YANAN	reporter.nih.gov
Endocannabinoid Signaling during Early Pregnancy	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021 to 2024	$1,933,902	July 1, 1990	May 31, 2026	DEY, SUDHANSU K	reporter.nih.gov
Placental Genomics in the Developmental Consequences of Marijuana Use in Pregnancy	NIH	National Institute on Drug Abuse	2023 to 2025	$1,916,774	June 1, 2023	March 31, 2028	STROUD, LAURA R	reporter.nih.gov
Endocannabinoid Modulation of the Habenular Stress Response	NIH	National Institute of Mental Health	2021 to 2025	$1,912,500	December 1, 2020	October 31, 2026	MCLAUGHLIN, RYAN JOSEPH	reporter.nih.gov
Lipid transport in the intestine	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$1,906,281	May 1, 1987	March 31, 2027	STORCH, JUDITH	reporter.nih.gov
Endocannabinoids regulate microglia in developing brain	NIH	National Institute on Drug Abuse	2022 to 2025	$1,904,331	April 1, 2016	February 28, 2027	MCCARTHY, MARGARET M.	reporter.nih.gov
Fatty acid binding-proteins and endocannabinoids in the retina; roles in glial reactivity and reprogramming of Muller glia into progenitor cells	NIH	National Eye Institute	2021 to 2025	$1,880,088	January 1, 2021	November 30, 2026	FISCHER, ANDY J	reporter.nih.gov
Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid	NIH	National Institute on Drug Abuse	2021 to 2024	$1,847,120	July 1, 2020	May 31, 2026	LAKSHMANA, MADEPALLI KRISHNAPPA	reporter.nih.gov
Endocannabinoid Metabolism in Acute Pain	NIH	National Institute on Drug Abuse	2021 to 2024	$1,844,228	April 15, 2020	February 28, 2026	KACZOCHA, MARTIN	reporter.nih.gov
HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids	NIH	National Institute on Drug Abuse	2021 to 2024	$1,839,474	March 15, 1992	February 28, 2026	THAYER, STANLEY A	reporter.nih.gov
Targeting the Endocannabinoid System for Headache Intervention	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$1,793,296	January 1, 2023	December 31, 2027	MILNES, TALLY MARIE	reporter.nih.gov
Astrocyte activity in amygdala-related fear conditioned behaviors	NIH	National Institute of Mental Health	2021 to 2024	$1,788,616	June 1, 2020	March 31, 2026	ARAQUE, ALFONSO	reporter.nih.gov
Gene-environment interaction: the brain CRF system in alcohol preferring msP rats	NIH	National Institute on Alcohol Abuse and Alcoholism	2021 to 2025	$1,774,951	July 1, 2021	June 30, 2027	ROBERTO, MARISA	reporter.nih.gov
Mechanisms underlying the influence of stress on drug-seeking behavior	NIH	National Institute on Drug Abuse	2023 to 2025	$1,764,926	July 1, 2023	April 30, 2028	MANTSCH, JOHN R	reporter.nih.gov
Lipid Imaging in Traumatic Brain Injury by High Resolution GCIB-secondary Ion Mass Spectrometry	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$1,756,092	July 1, 2012	July 31, 2028	BAYIR, HÜLYA	reporter.nih.gov
Uncovering sleep and circadian mechanisms contributing to adverse metabolic health	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$1,755,898	August 15, 2023	July 31, 2027	MCHILL, ANDREW WILLIAM	reporter.nih.gov
Activity-dependent endocannabinoid control in epilepsy	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$1,751,643	April 1, 2023	March 31, 2028	SOLTESZ, IVAN	reporter.nih.gov
Enteric glia and visceral pain	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$1,715,750	March 1, 2024	February 28, 2028	GULBRANSEN, BRIAN D.	reporter.nih.gov
Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences	NIH	National Institute on Drug Abuse	2022 to 2025	$1,708,678	April 1, 2016	May 31, 2028	MAITRA, RANGAN	reporter.nih.gov
Neuro-immune mechanisms of minor cannabinoids in inflammatory and neuropathic pain	NIH	National Center for Complementary & Integrative Health	2021 to 2023	$1,692,291	September 15, 2019	June 30, 2025	HELLMAN, JUDITH	reporter.nih.gov
Intestinal Homeostasis Induced by Commensals	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,680,144	July 15, 2020	April 30, 2025	MCCORMICK, BETH A	reporter.nih.gov
Circuit and Synaptic Mechanisms of Endocannabinoid-Opioid Crosstalk	NIH	National Institute on Drug Abuse	2023 to 2025	$1,647,735	September 30, 2022	June 30, 2027	RAJADHYAKSHA, ANJALI M	reporter.nih.gov
Development of selective cannabinoid receptor 2 agonists for treatment of addiction	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$1,621,997	April 19, 2022	April 30, 2027	SHAMLOO, MEHRDAD	reporter.nih.gov
Supplement to Basal Forebrain Modulation of Olfactory Bulb Function	NIH	National Institute on Deafness and Other Communication Disorders	2021 to 2022	$1,608,566	February 1, 2011	August 31, 2023	PUCHE, ADAM C	reporter.nih.gov
Activity-Dependent Plasticity in an Associative Hippocampal Circuit: Mechanisms, Synaptic Learning Rules and Involvement in Disease	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$1,598,211	August 1, 2019	June 30, 2025	CASTILLO, PABLO E	reporter.nih.gov
Novel therapeutic approach for NASH	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,553,952	June 4, 2020	May 31, 2025	MAITRA, RANGAN	reporter.nih.gov
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence	NIH	National Institute on Drug Abuse	2021 to 2023	$1,551,552	April 15, 2019	February 28, 2026	HOHMANN, ANDREA GRACE	reporter.nih.gov
Modeling the effects of chronic marijuana use on neuroinflammation and HIV-related neuronal injury	NIH	National Institute on Drug Abuse	2023 to 2025	$1,527,736	September 30, 2020	August 31, 2026	MEADE, CHRISTINA S	reporter.nih.gov
Role of Microglia in Prenatal ethanol exposure-induced Impairment of Endocannabinoid Signaling	NIH	National Institute on Alcohol Abuse and Alcoholism	2022 to 2025	$1,451,013	September 22, 2022	June 30, 2027	SHEN, ROH-YU	reporter.nih.gov
Cannabis Use Impact on Pain and Recovery Post-Surgery - The Role of the Endocannabinoid System	NIH	National Institute of Neurological Disorders and Stroke	2025	$1,443,561	September 5, 2025	August 31, 2030	INGRAM, SUSAN L	reporter.nih.gov
Therapeutic Targeting of Monoacylglycerol Lipase After Traumatic Brain Injury	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2024	$1,436,743	August 1, 2020	April 30, 2026	VAIBHAV, KUMAR	reporter.nih.gov
Estrogen regulation of the prefrontal cortex and drug seeking	NIH	National Institute on Drug Abuse	2021 to 2024	$1,390,995	July 1, 2020	April 30, 2026	MANTSCH, JOHN R.	reporter.nih.gov
Sleep-dependent synaptic homeostasis in Alzheimer's disease	NIH	National Institute on Aging	2024 to 2025	$1,390,274	April 15, 2021	March 31, 2027	DIERING, GRAHAM HUGH	reporter.nih.gov
Biosynthesis and biological mechanism of minor cannabinoids	NIH	National Center for Complementary & Integrative Health	2024 to 2025	$1,373,136	December 20, 2023	October 31, 2028	MOORE, BRADLEY S	reporter.nih.gov
Stress, 'comfort' food, and obesity	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,369,344	May 8, 2020	April 30, 2026	ULRICH-LAI, YVONNE MICHELLE	reporter.nih.gov
Repeated Administration of Cannabis Varying in THC and CBD: Effects on Abuse Liability, Experimental Pain and Plasma Endocannabinoids	NIH	National Institute on Drug Abuse	2022 to 2023	$1,341,614	August 15, 2022	May 31, 2028	HANEY, MARGARET	reporter.nih.gov
Alpha2delta-mediated control of neuronal signaling	NIH	National Institute of Neurological Disorders and Stroke	2022 to 2025	$1,338,101	March 15, 2022	February 28, 2027	SCHNELL, ERIC	reporter.nih.gov
Development of sterol carrier protein 2 inhibitors as anxiolytics	NIH	National Institute of Mental Health	2024 to 2025	$1,330,698	July 1, 2024	February 29, 2028	HILLARD, CECILIA J	reporter.nih.gov
The role of endocannabinoids in circadian disruption induced metabolic dysregulation	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,323,387	December 1, 2019	November 30, 2024	KARATSOREOS, ILIA NICHOLAS	reporter.nih.gov
Structural basis for K2P channel gating and modulation	NIH	National Institute of General Medical Sciences	2022 to 2025	$1,314,428	September 1, 2022	July 31, 2027	BROHAWN, STEPHEN GRAF	reporter.nih.gov
Cannabis use and the endocannabinoid system in bipolar disorder	NIH	National Institute on Drug Abuse	2021 to 2022	$1,310,628	May 1, 2018	February 29, 2024	PERRY, WILLIAM	reporter.nih.gov
Activity-dependent degradation of a neuromodulator	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$1,216,236	July 1, 2019	June 30, 2025	LIU, SIQIONG JUNE	reporter.nih.gov
Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use Disorders	NIH	National Institute on Alcohol Abuse and Alcoholism	2021 to 2025	$1,189,773	September 1, 2017	February 29, 2028	PATEL, SACHIN	reporter.nih.gov
Circuit and Synaptic Mechanisms of Endocannabinoid-Opioid Crosstalk	NIH	National Institute on Drug Abuse	2022 to 2023	$1,157,008	September 30, 2022	October 31, 2023	RAJADHYAKSHA, ANJALI M	reporter.nih.gov
Circuit-specific actions of endocannabinoids in stress and mood disorders	NIH	National Institute of Mental Health	2021 to 2023	$1,155,000	September 11, 2019	August 31, 2025	LIU, QING-SONG	reporter.nih.gov
Effects of host endocannabinoid signaling on Enterobacteriaceae infection	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$1,140,243	June 6, 2024	April 30, 2029	ELLERMANN, MELISSA	reporter.nih.gov
Metabolic correlates of disease activity and disability progression in pediatric MS	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2023	$1,103,912	April 1, 2021	March 31, 2024	WAUBANT, EMMANUELLE LAURENCE	reporter.nih.gov
Central Amygdala Glutamatergic Circuits in Fear Learning and Extinction	NIH	National Institute of Mental Health	2021 to 2023	$1,100,925	April 21, 2022	September 30, 2024	PATEL, SACHIN	reporter.nih.gov
Endocannabinoid System Engagement and Clinical Symptom Change with Cannabidiol for Social Anxiety Disorder	NIH	National Center for Complementary & Integrative Health	2022 to 2023	$1,099,216	January 18, 2022	April 30, 2025	TAYLOR, CHARLES	reporter.nih.gov
Imaging Alterations in Endocannabinoid Metabolism in Depression and Suicide	NIH	National Institute of Mental Health	2024 to 2025	$1,078,719	July 1, 2024	January 31, 2029	MIZRAHI, ROMINA	reporter.nih.gov
Cannabinoid receptor control of a DRN to VTA pathway and its role in affective states	NIH	National Institute on Drug Abuse	2021 to 2023	$1,042,875	March 1, 2019	December 31, 2023	CHEER, JOSEPH F	reporter.nih.gov
Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation	NIH	National Institute of General Medical Sciences	2022 to 2025	$1,037,393	August 15, 2022	July 31, 2027	STARK, RUTH E.	reporter.nih.gov
Endocannabinoid Biosynthesis in Inflammation and Pain	NIH	National Institute on Drug Abuse	2023 to 2025	$1,034,700	February 1, 2024	January 31, 2029	HSU, KU-LUNG	reporter.nih.gov
Synthesis of peripherally active CB1 agonists as analgesics	NIH	National Institute of Neurological Disorders and Stroke	2021	$1,033,359	September 29, 2021	June 30, 2023	MAJUMDAR, SUSRUTA	reporter.nih.gov
Alternative Splicing & Differential Expression of Lipases in Host-Microbe Interactions	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$1,030,241	December 20, 2023	October 31, 2028	GHAZI, ARJUMAND	reporter.nih.gov
Gut-brain endocannabinoid signaling in feeding behavior and obesity	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,021,476	July 1, 2019	March 31, 2025	DIPATRIZIO, NICHOLAS VINCENT	reporter.nih.gov
FABP5: Novel Functions in Pain Modulation	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$997,694	March 1, 2024	February 28, 2029	KACZOCHA, MARTIN	reporter.nih.gov
Brain Mechanisms of Avoidance: Implications for Addiction and Anxiety	NIH	National Institute on Drug Abuse	2021 to 2022	$985,276	September 30, 2018	June 30, 2024	LEDOUX, JOSEPH E	reporter.nih.gov
Effects of Early-life Cannabinoid Exposure on Prefrontal Circuitry and Cognitive Behavior across Development	NIH	National Institute on Drug Abuse	2024 to 2025	$967,695	June 1, 2024	March 31, 2029	CHE, ALICIA YUE	reporter.nih.gov
Role of the circadian rhythm on endocannabinoid response to an acute stress	NIH	National Heart, Lung, and Blood Institute	2021 to 2025	$956,720	January 1, 2021	December 31, 2025	BOWLES, NICOLE P	reporter.nih.gov
Investigating the bidirectional relationship between circadian rhythms and cannabinoid use	NIH	National Institute on Drug Abuse	2024 to 2025	$887,766	July 15, 2024	May 31, 2029	KETCHESIN, KYLE	reporter.nih.gov
Role of prelimbic cortical endocannabinoid signaling in enhanced cocaine-seeking behavior following combined repeated stress and cocaine use in rats	NIH	National Institute on Drug Abuse	2024 to 2025	$832,475	March 1, 2024	January 31, 2029	MCREYNOLDS, JAYME ROSE	reporter.nih.gov
FABPs: Novel Roles in Pain and Inflammation	NIH	National Institute on Drug Abuse	2021 to 2022	$790,902	July 1, 2014	May 31, 2024	KACZOCHA, MARTIN	reporter.nih.gov
Neuropathic Pain-induced Depression: the Role of mPFC Endocannabinoids	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$779,283	August 15, 2019	January 31, 2024	PAN, BIN	reporter.nih.gov
Endocannabinoids in Neurodegenerative Diseases	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$774,165	June 15, 2012	April 30, 2023	CHEN, CHU	reporter.nih.gov
Endocannabinoid Metabolism and Synaptic Function	NIH	National Institute of Mental Health	2021 to 2022	$773,125	February 5, 2018	November 30, 2023	CHEN, CHU	reporter.nih.gov
Structure and Function of CB2 Receptor	NIH	National Institute on Drug Abuse	2021	$763,601	September 30, 2017	August 31, 2023	MAKRIYANNIS, ALEXANDROS	reporter.nih.gov
CB1 receptors mediate metaplasticity in the cerebellar circuit	NIH	National Institute of Neurological Disorders and Stroke	2024 to 2025	$761,634	March 1, 2024	November 30, 2028	PUGH, JASON RICHARD	reporter.nih.gov
Endocannabinoid Control of Cholinergic Transmission and the Pursuit of Reward	NIH	National Institute of Mental Health	2025	$760,143	May 1, 2025	February 28, 2030	CHEER, JOSEPH F	reporter.nih.gov
The role of gut-heart axis in acute alcohol intoxication-induced adverse cardiovascular events	NIH	National Institute on Alcohol Abuse and Alcoholism	2023 to 2025	$747,000	August 1, 2023	July 31, 2027	PALOCZI, JANOS	reporter.nih.gov
Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$746,308	August 1, 2019	August 31, 2023	CAMILLERI, MICHAEL L.	reporter.nih.gov
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo	NIH	National Institute on Drug Abuse	2021 to 2022	$724,673	June 1, 2018	April 30, 2024	FITTING, SYLVIA	reporter.nih.gov
Oral THC consumption during adolescence and its impact on adult mouse brain	NIH	National Institute on Drug Abuse	2025	$716,455	July 1, 2025	March 31, 2030	STELLA, NEPHI	reporter.nih.gov
Prenatal marijuana: Impact on infant neurobehavior, stress, & epigenetic mechanisms	NIH	National Institute on Drug Abuse	2021	$694,540	September 1, 2017	July 31, 2025	STROUD, LAURA R	reporter.nih.gov
Development of non-opioid, non-addictive analgesics for treating neuropathic pain	NIH	National Institute of Neurological Disorders and Stroke	2025	$675,107	March 18, 2025	January 31, 2030	THAKUR, GANESH A	reporter.nih.gov
Neurodevelopmental Effects of THC on The VTA Dopamine System and Behavior	NIH	National Institute on Drug Abuse	2021 to 2022	$670,144	September 30, 2018	May 31, 2024	CHEER, JOSEPH F	reporter.nih.gov
Quorum Sensing Regulation of EHEC Virulence Genes	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$668,955	July 1, 2003	May 31, 2022	SPERANDIO, VANESSA	reporter.nih.gov
Biopsychosocial predictors of opioid use for pediatric postsurgical pain	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021 to 2025	$666,906	May 1, 2021	April 30, 2026	STONE, AMANDA LEIGH	reporter.nih.gov
Development of selective cannabinoid receptor 2 agonists for treatment of addiction	NIH	National Institute of Neurological Disorders and Stroke	2022	$661,980	April 19, 2022	March 31, 2023	SHAMLOO, MEHRDAD	reporter.nih.gov
Using Cannabinoids to Enhance Opioid Analgesic Effects in Humans	NIH	National Institute on Drug Abuse	2021	$657,143	August 1, 2016	June 30, 2023	DUNN, KELLY E	reporter.nih.gov
Alcohol and Traumatic Brain Injury; Neuronal and Behavioral Consequences	NIH	National Institute on Alcohol Abuse and Alcoholism	2021 to 2022	$657,000	May 10, 2018	March 31, 2024	MOLINA, PATRICIA E.	reporter.nih.gov
Orexin modulation of brain reward-brain stress system interactions in alcohol withdrawal anxiety	NIH	National Institute on Alcohol Abuse and Alcoholism	2022 to 2025	$654,468	March 1, 2022	February 28, 2027	AVEGNO, ELIZABETH MINOR	reporter.nih.gov
Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model	NIH	National Institute on Drug Abuse	2024	$640,462	July 1, 2024	June 30, 2026	WILLIAMS, DIONNA WHITNEY	reporter.nih.gov
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation	NIH	National Institute of Mental Health	2021	$628,506	June 15, 2016	January 1, 2022	PATEL, SACHIN	reporter.nih.gov
Examining the longitudinal impact of circulating endocannabinoid levels on neurocognition, impulsivity, and early cannabis use patterns in youth enrolled in the ABCD Study	NIH	National Institute on Drug Abuse	2025	$621,186	July 1, 2025	March 31, 2030	LISDAHL, KRISTA MAURINE	reporter.nih.gov
Perinatal cannabinoids delay KCC2 expression and lead to neurodevelopmental abnormalities	NIH	National Institute on Drug Abuse	2021 to 2022	$619,214	August 1, 2018	June 30, 2024	MACKIE, KENNETH	reporter.nih.gov
Preclinical assessment of a Sterol Carrier Protein-2 inhibitor in multidimensional opioid withdrawal.	NIH	National Institute on Drug Abuse	2022 to 2024	$573,400	August 1, 2022	July 31, 2025	MOORE, CATHERINE FRANCES	reporter.nih.gov
A CB1 Antagonist for Treatment of Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024	$572,743	September 1, 2024	June 30, 2025	ALAPAFUJA, SHAKIRU OLAJIRE	reporter.nih.gov
The role of cannabinoid 1 receptor in age-associated diseases	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$551,696	September 12, 2025	August 31, 2028	KIM, YOO	reporter.nih.gov
Multimodal Assessment of Cannabinoid Target Engagement in Adults with Obsessive-Compulsive Disorder	NIH	National Institute of Mental Health	2021 to 2023	$513,527	July 1, 2021	September 8, 2023	KAYSER, REILLY REYNS	reporter.nih.gov
The influence of aerobic exercise on consolidation of fear extinction learning in PTSD	NIH	National Institute of Mental Health	2023 to 2025	$503,029	March 3, 2023	February 29, 2028	CROMBIE, KEVIN M	reporter.nih.gov
Endocannabinoids and the development of extinction recall neural circuitry in adolescents	NIH	National Institute of Mental Health	2021 to 2023	$493,638	July 1, 2019	June 30, 2024	MARUSAK, HILARY	reporter.nih.gov
Corticolimbic circuitry in adaptive stress coping behavior and subsequent alcohol drinking	NIH	National Institute on Alcohol Abuse and Alcoholism	2024 to 2025	$493,384	August 15, 2024	July 31, 2027	ORNELAS, LAURA C.	reporter.nih.gov
Targeting the endocannabinoid signaling in chemical threat agents-induced lung injury	NIH	National Institute of Environmental Health Sciences	2025	$489,008	September 15, 2025	September 14, 2027	NAGRE, NAGARAJA	reporter.nih.gov
CHEMOPROTEOMIC METHODS FOR SERINE HYDROLASE INHIBITOR DEVELOPMENT	NIH	National Institute on Drug Abuse	2021	$486,911	April 1, 2012	March 31, 2022	CRAVATT, BENJAMIN F	reporter.nih.gov
Cannabinoids as an environmental risk factor of testicular cancer: Assessment using cell culture models of human and mouse primordial germ cells and by exposure of pregnant mice	NIH	National Institute on Drug Abuse	2024 to 2025	$473,500	May 15, 2024	April 30, 2027	SHIODA, TOSHIHIRO	reporter.nih.gov
Endocannabinoid System Alterations in Opioid Use Disorder (OUD)	NIH	National Institute on Drug Abuse	2022 to 2023	$460,625	August 1, 2022	July 31, 2024	BASSIR NIA, ANAHITA	reporter.nih.gov
Acute effects of THC in older adults	NIH	National Institute on Drug Abuse	2024 to 2025	$460,625	August 1, 2024	July 31, 2027	D'SOUZA, DEEPAK CYRIL	reporter.nih.gov
Pulmonary Disfunction after Polysubstance Exposure: Mechanistic Identification of Inflammatory Mediators	NIH	National Institute of General Medical Sciences	2022 to 2024	$448,917	July 8, 2022	November 30, 2025	SIVARAMAN, VIJAY	reporter.nih.gov
Endocannabinoid system as a therapeutic target for PVR	NIH	National Eye Institute	2023	$445,262	September 30, 2023	July 31, 2025	SONG, ZHAO-HUI	reporter.nih.gov
Stemming the opioid-induced pain cascade via cannabinoid modulation	NIH	National Institute on Drug Abuse	2021 to 2022	$442,750	July 1, 2021	June 30, 2025	KINSEY, STEVEN G.	reporter.nih.gov
The Developmental Effects of Environmental Enrichment on the Minor Cannabinoid Drug Reward and Cannabinoid Receptor Levels	NIH	National Institute on Drug Abuse	2024	$440,924	August 1, 2024	July 31, 2027	STAIRS, DUSTIN JEFFREY	reporter.nih.gov
Molecular and Behavioral Impacts of Developmental OP Neurotoxicity	NIH	National Institute of Environmental Health Sciences	2021	$436,465	May 5, 2021	April 30, 2025	CARR, RUSSELL L	reporter.nih.gov
Cannabinoid-2 receptor signaling in vesicant induced lung injury	NIH	National Institute of Environmental Health Sciences	2021 to 2022	$432,598	August 18, 2021	June 30, 2024	NAGRE, NAGARAJA	reporter.nih.gov
Neurovascular Uncoupling and Cognitive Impairments of Long COVID in Aging	NIH	National Institute on Aging	2022 to 2023	$429,000	September 30, 2022	August 31, 2024	WANG, YANG	reporter.nih.gov
Isolation and Pharmacological Evaluation of Impurities in Δ-8-THC Products	NIH	National Institute on Drug Abuse	2024 to 2025	$427,879	April 15, 2024	March 31, 2027	ELSOHLY, MAHMOUD A	reporter.nih.gov
Role of CB1R expressed in the prefrontal cortex in the control of locomotion	NIH	National Institute on Drug Abuse	2023 to 2024	$427,625	September 15, 2023	August 31, 2025	STELLA, NEPHI	reporter.nih.gov
Differential control of 2-AG’s activity at CB1R by ABHD6 and MAGL	NIH	National Institute on Drug Abuse	2023 to 2024	$427,625	April 1, 2023	March 31, 2025	STELLA, NEPHI	reporter.nih.gov
In vivo calcium imaging during appetitive learning in HIV Tat transgenic mice exposed to cannabis	NIH	National Institute on Drug Abuse	2023 to 2024	$427,625	March 15, 2023	February 28, 2026	FITTING, SYLVIA	reporter.nih.gov
Regulation of Fat Taste by Adiposity and Endocannabinoids: Implications for Obesity	NIH	National Institute on Deafness and Other Communication Disorders	2023 to 2024	$426,361	December 1, 2022	November 30, 2025	BRESLIN, PAUL A. S	reporter.nih.gov
A New Model of Gestational Cannabis Exposure	NIH	National Institute on Drug Abuse	2021 to 2022	$424,875	July 15, 2021	June 30, 2023	MEDINA, ALEXANDRE ESTEVES	reporter.nih.gov
Mechanism and Therapeutic Potential of CBD to Repair Blood-Brain Barrier Dysfunction in Epilepsy	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2024	$420,750	April 1, 2023	March 31, 2026	BAUER, BJOERN	reporter.nih.gov
Circuitry- and cell-specific exploration of CB1R positive allosteric modulators in neuroHIV	NIH	National Institute on Drug Abuse	2025	$416,351	September 1, 2025	May 31, 2030	FITTING, SYLVIA	reporter.nih.gov
Establishing Behavioral and Biological Predictors of Problematic Cannabis Use	NIH	National Institute on Drug Abuse	2021 to 2022	$408,556	April 15, 2021	March 31, 2024	MCLAUGHLIN, RYAN JOSEPH	reporter.nih.gov
The effect of exercise on the endocannabinoid system as a pathway to cardiometabolic health in adults with overweight/obesity.	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$404,264	September 15, 2021	August 31, 2024	BRELLENTHIN, ANGELIQUE GABRIELLE	reporter.nih.gov
Cannabinoid and opioid modulation of descending pain circuits in chronic pain	NIH	National Institute on Drug Abuse	2021	$401,703	July 1, 2017	April 30, 2023	HEINRICHER, MARY MAGDALEN	reporter.nih.gov
Inhibition of fatty acid amide hydrolase as a novel strategy to prevent nephrotoxicity of cisplatin.	NIH	National Cancer Institute	2022 to 2023	$397,970	August 16, 2022	July 31, 2025	LI, NINGJUN	reporter.nih.gov
Endocannabinoid Biosynthesis in Inflammation and Pain	NIH	National Institute on Drug Abuse	2021	$397,603	September 15, 2017	June 30, 2022	HSU, KU-LUNG	reporter.nih.gov
Allosteric control of monoacylglyceride lipase (MGL) activity	NIH	National Institute on Drug Abuse	2022 to 2023	$397,000	May 1, 2022	October 31, 2024	PIOMELLI, DANIELE	reporter.nih.gov
Optimization of cannabidiol-based formulations in autism spectrum disorder	NIH	National Institute of Neurological Disorders and Stroke	2025	$396,988	January 1, 2025	December 31, 2028	KAPLAN, JOSH	reporter.nih.gov
Exploring the antecendents and consequences of cannabis use in the context of coping: An experimental study	NIH	National Institute on Drug Abuse	2024 to 2025	$390,405	August 1, 2024	July 31, 2029	SKRZYNSKI, CARILLON JOY	reporter.nih.gov
Context-induced Cocaine Relapse: Influence of Cocaine Memory Reconsolidation	NIH	National Institute on Drug Abuse	2021	$380,780	February 1, 2010	March 31, 2024	FUCHS LOKENSGARD, RITA A	reporter.nih.gov
Dual Fatty Acid Amide Hydrolase (FAAH)/Monoacylglycerol lipase (MAGL) Inhibitors for Cannabis Use Disorder (CUD).	NIH	National Institute on Drug Abuse	2023 to 2025	$375,000	June 1, 2023	August 31, 2025	ALAPAFUJA, SHAKIRU OLAJIRE	reporter.nih.gov
Central Amygdala Glutamatergic Circuits in Fear Learning and Extinction	NIH	National Institute of Mental Health	2021	$371,684	September 9, 2019	January 1, 2022	PATEL, SACHIN	reporter.nih.gov
Oxytocin Induces Retrograde Metaplasticity to Attenuate CocainePreference Behavior	NIH	National Institute on Drug Abuse	2023 to 2024	$371,023	September 30, 2023	August 31, 2025	LEONG, KAH CHUNG	reporter.nih.gov
Traumatic stress increases alcohol drinking via endocannabinoid disinhibition of basolateral amygdala	NIH	National Institute on Alcohol Abuse and Alcoholism	2021	$369,493	September 15, 2017	July 31, 2024	GILPIN, NICHOLAS WARREN	reporter.nih.gov
THERAPY FOR ALCOHOL USE DISORDER	NIH	National Institute on Alcohol Abuse and Alcoholism	2023	$368,673	September 25, 2023	August 31, 2025	SELTZMAN, HERBERT H	reporter.nih.gov
Regulation of TRP channels and visual transduction	NIH	National Eye Institute	2021	$366,129	January 1, 1995	January 31, 2022	MONTELL, CRAIG	reporter.nih.gov
Cannabinoid Signaling Interactions During Axon Development in situ	NIH	National Institute on Drug Abuse	2023	$364,250	August 1, 2023	July 31, 2026	ELUL, TAMIRA	reporter.nih.gov
Developing multitarget enzyme inhibitors as safe and effective anti-migraine treatments	NIH	National Institute of General Medical Sciences	2023 to 2025	$357,093	August 1, 2023	June 30, 2027	KANDASAMY, RAM	reporter.nih.gov
The Role of Endocannabinoids in Adulthood Alcohol Drinking After Adolescent Social Isolation	NIH	National Institute on Alcohol Abuse and Alcoholism	2023 to 2024	$352,296	July 15, 2023	September 30, 2024	VOZELLA, VALENTINA	reporter.nih.gov
Cannabinoid control of epilepsy	NIH	National Institute of Neurological Disorders and Stroke	2021	$350,775	July 1, 2017	March 31, 2023	SOLTESZ, IVAN	reporter.nih.gov
Endocannabinoid modulation of behavioral engagement via an aPVT-NAc circuit	NIH	National Institute on Drug Abuse	2024 to 2025	$349,250	February 1, 2024	July 31, 2026	MARCUS, DAVID J.	reporter.nih.gov
Cannabinoid CB2 Agonists for Treatment of Breast Cancer Induced Bone Pain	NIH	National Cancer Institute	2021	$337,106	March 1, 2010	February 28, 2023	VANDERAH, TODD W	reporter.nih.gov
Role of CB1 Receptors in Opioid Tolerance During Pain	NIH	National Institute on Drug Abuse	2021 to 2022	$333,000	September 30, 2019	August 31, 2023	WILSON-POE, ADRIANNE RAE	reporter.nih.gov
Functional Implications of Sex Differences in Hippocampal Endocannabinoid Signaling	NIH	National Institute of Mental Health	2022 to 2023	$328,000	July 1, 2022	June 30, 2025	REICH, CHRISTIAN G	reporter.nih.gov
Role of the transcription elongation and splicing factor TCER-1 in repressing immunity and promoting fertility	NIH	National Institute on Aging	2021	$320,825	April 1, 2021	March 31, 2023	GHAZI, ARJUMAND	reporter.nih.gov
Treatment for cannabis use disorder	NIH	National Institute on Drug Abuse	2022	$319,898	August 1, 2022	July 31, 2025	SELTZMAN, HERBERT H	reporter.nih.gov
Sex-specific critical periods determine the effects of cannabinoids on the mesocorticolimbic system	NIH	National Institute on Drug Abuse	2021	$310,657	August 1, 2017	May 31, 2023	MACKIE, KENNETH	reporter.nih.gov
Therapeutic Antibodies for Treating Inflammatory Bowel Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$300,241	May 1, 2021	April 30, 2023	SCHWIMMER, LAUREN JENNIFER	reporter.nih.gov
Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus.	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2023 to 2024	$293,749	June 1, 2023	May 31, 2025	DRAGANSKI, ANDREW R	reporter.nih.gov
Antibody agonist for a G protein-coupled receptor as a treatment for pain in endometriosis	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2022	$292,942	June 10, 2022	May 31, 2024	TAKEUCHI, TOSHIHIKO	reporter.nih.gov
Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use Disorders	NIH	National Institute on Alcohol Abuse and Alcoholism	2021	$289,707	September 1, 2017	January 1, 2022	PATEL, SACHIN	reporter.nih.gov
Development of dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors as a Promising Therapeutic Strategy for the Treatment of Acute and Chronic Pain	NIH	National Institute of General Medical Sciences	2021 to 2022	$284,000	May 1, 2020	April 30, 2023	PECIC, STEVAN	reporter.nih.gov
Investigating the therapeutic potential of CB2 in modulation of inflammation in the mammary gland during lactation	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2022	$282,665	September 1, 2022	July 31, 2025	PEREZ LASPIUR, JULIANA	reporter.nih.gov
Experimental evaluation of the mechanisms driving acute stress potentiation of drug cue reactivity in Cannabis Use Disorder	NIH	National Institute on Drug Abuse	2024 to 2025	$270,074	May 1, 2024	August 31, 2025	MACATEE, RICHARD	reporter.nih.gov
Therapeutic Strategy for NASH	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$256,475	September 21, 2021	August 31, 2023	SELTZMAN, HERBERT H	reporter.nih.gov
Neural circuit control of mesolimbic dopamine and reward	NIH	National Institute on Drug Abuse	2021	$249,000	September 1, 2020	August 31, 2023	COVEY, DANIEL PATRICK	reporter.nih.gov
ENDOCANNABINOID REINFORCEMENT OF PHYSICAL ACTIVITY	NIH	National Institute on Drug Abuse	2025	$249,000	August 1, 2025	July 31, 2028	LETSINGER, AYLAND CASH	reporter.nih.gov
Neural circuit control of mesolimbic dopamine and reward	NIH	National Institute on Drug Abuse	2022	$245,741	September 1, 2020	August 31, 2023	COVEY, DANIEL PATRICK	reporter.nih.gov
Nutrition-based interventions to ameliorate pain in sickle cell disease	NIH	National Center for Complementary & Integrative Health	2024 to 2025	$241,268	April 1, 2024	March 31, 2026	ARGUETA, DONOVAN ALEXANDER	reporter.nih.gov
Circuit Modulation in Spinocerebellar Ataxias: Mechanisms and Impact	NIH	National Institute of Neurological Disorders and Stroke	2025	$233,280	December 1, 2024	November 30, 2029	SRINIVASAN, SHARAN RAM	reporter.nih.gov
Impact on adult mouse brain of oral THC and CBD consumption during adolescence	NIH	National Institute on Drug Abuse	2021	$233,250	July 15, 2020	June 30, 2023	STELLA, NEPHI	reporter.nih.gov
Pregnenolone as a Treatment for Cannabis Intoxication	NIH	National Institute on Drug Abuse	2025	$232,625	September 1, 2025	August 31, 2027	WOLINSKY, DAVID	reporter.nih.gov
Inhibition of diacylglycerol lipase α as a novel strategy to mitigate the nephrotoxicity of cisplatin	NIH	National Cancer Institute	2025	$227,221	January 1, 2025	December 31, 2026	LI, NINGJUN	reporter.nih.gov
Sex-specific development of seizure activity following endocannabinoid system manipulation in the fetal brain	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$225,792	July 1, 2022	June 30, 2027	JONES-MUHAMMAD, MARIA AISHA	reporter.nih.gov
Examining the Role of Circulating Endocannabinoids in Predicting Alcohol Relapse Risk and Resiliency	NIH	National Institute on Alcohol Abuse and Alcoholism	2021	$210,781	April 10, 2020	March 31, 2023	MASON, BARBARA J	reporter.nih.gov
Corticolimbic circuitry in adaptive stress coping behavior and subsequent alcohol drinking	NIH	National Institute on Alcohol Abuse and Alcoholism	2022 to 2023	$204,658	August 1, 2022	July 31, 2024	ORNELAS, LAURA C.	reporter.nih.gov
Simultaneous prenatal alcohol and cannabinoid exposure & offspring corticostriatal neurocircuitry	NIH	National Institute on Alcohol Abuse and Alcoholism	2022 to 2024	$199,840	May 1, 2022	February 28, 2025	ROUZER, SIARA	reporter.nih.gov
Development of Tetrahydrocannabivarin as a Treatment for Smokers	NIH	National Institute on Drug Abuse	2024	$196,875	August 15, 2024	July 31, 2026	RAY, LARA A.	reporter.nih.gov
TRPV1 signaling as a sex-specific mechanism of contextual fear generalization	NIH	National Institute of Mental Health	2021	$196,250	February 1, 2020	December 31, 2023	SHANSKY, REBECCA M	reporter.nih.gov
Cannabinoid Receptor Type 2 Agonist as Potential Therapy for Neuroinflammation in HIV-1 Associated Neurocognitive Disorders	NIH	National Institute on Drug Abuse	2024	$194,940	January 1, 2024	December 31, 2024	MIN, ALICE KYUNGSUN	reporter.nih.gov
Cannabis, Depression and Neurobiological Function in Transition-Age Youth	NIH	National Institute on Drug Abuse	2022	$193,320	July 15, 2022	September 30, 2029	FISCHER, ADINA SHERI	reporter.nih.gov
Anandamide in blood pressure control	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$189,000	May 1, 2024	April 30, 2027	KLAWITTER, JELENA	reporter.nih.gov
Neurotensinergic-eCB modulation of reward and aversion via a PVT-NAc circuit	NIH	National Institute on Drug Abuse	2021 to 2023	$188,638	July 1, 2021	January 31, 2024	MARCUS, DAVID J.	reporter.nih.gov
In vitro and in vivo characterization of CB1 allosteric modulators	NIH	National Institute on Drug Abuse	2021 to 2022	$177,423	July 15, 2018	August 11, 2023	GAMAGE, THOMAS F	reporter.nih.gov
FAAH-regulated endocannabinoid signaling controls nociception in acute pancreatitis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$169,388	September 9, 2025	July 31, 2030	MABOU TAGNE, ALEX	reporter.nih.gov
Endogenous Cannabinoids in Inflammatory Airway Disease	NIH	National Center for Advancing Translational Sciences	2022 to 2023	$156,500	December 1, 2021	November 30, 2023	LEVY, JOSHUA M	reporter.nih.gov
Bacterial targeting of the P-glycoprotein/endocannabinoid axis for reducing intestinal inflammation in ulcerative colitis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$149,626	September 1, 2022	August 31, 2026	SALLIS, BENJAMIN FIDELIUS	reporter.nih.gov
Investigating the role of cannabinoid receptors in oligodendrocyte development	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2025	$143,807	February 1, 2023	December 31, 2025	MIRAMONTES, TANIA G	reporter.nih.gov
Alcohol exposure reverses fear conditioning-induced change in endocannabinoid signaling	NIH	National Institute on Alcohol Abuse and Alcoholism	2021 to 2023	$132,007	September 1, 2020	May 16, 2024	FAROOQ, MUHAMMAD A.	reporter.nih.gov
Dissecting PFC Endocannabinoid-THC -regulated circuits in movement behavior	NIH	National Institute on Drug Abuse	2022 to 2024	$130,541	March 16, 2022	March 15, 2025	ENGLISH, ANTHONY EDWARD	reporter.nih.gov
Cannabinoid Modulation of Neuroinflammation in Human iPSC Models of HIV Infection	NIH	National Institute on Drug Abuse	2021 to 2023	$126,231	July 1, 2021	December 21, 2023	STARR, ALEXANDER	reporter.nih.gov
Shared mechanisms of alcohol use disorder and Anxiety and effects of the endocannabinoid system	NIH	National Institute on Alcohol Abuse and Alcoholism	2021 to 2023	$124,883	August 1, 2021	July 31, 2024	MARTIN-WILLETT, RENEE	reporter.nih.gov
Evaluation of peripheral cannabinoid receptors as a target for pain management	NIH	National Institute on Drug Abuse	2021 to 2022	$121,722	April 1, 2020	December 31, 2022	SLIVICKI, RICHARD	reporter.nih.gov
Exploring differential biological and psychological effects of regular alcohol and cannabis use in humans	NIH	National Institute on Alcohol Abuse and Alcoholism	2022 to 2025	$118,046	December 15, 2022	December 14, 2025	DRENNAN, MEGGAN L	reporter.nih.gov
PHARMACOLOGICAL ANTAGONISM AND GENETIC MANIPULATION OF CANNABINOID CB1 RECEPTORS IN THE AMYGDALA TO REDUCE PROTRACTED ETHANOL CONSUMPTION	NIH	National Institute on Alcohol Abuse and Alcoholism	2021 to 2022	$102,788	April 15, 2020	April 14, 2023	DULMAN, RUSSELL SCOTT	reporter.nih.gov
Chemical biology tools for investigating heteromeric complexes of cannabinoid receptors	NIH	National Institute of General Medical Sciences	2021 to 2022	$102,514	August 1, 2021	August 31, 2022	LAGUERRE, AURELIEN	reporter.nih.gov
Involvement of Gq Signaling in the Mobilization of 2-Arachidonoylglycerol by Corticosterone in the Prefrontal Cortex	NIH	National Institute on Drug Abuse	2024 to 2025	$98,512	April 1, 2024	March 31, 2027	LASKOWSKI, LAUREN J	reporter.nih.gov
Input specific adaptations to glutamatergic strength and plasticity on PFC PV-INs following ethanol drinking	NIH	National Institute on Alcohol Abuse and Alcoholism	2024 to 2025	$98,512	September 1, 2024	August 31, 2027	FABIAN, CARLY B	reporter.nih.gov
Evaluating Contributors to Relapse in Comorbid Major Depressive Disorder and Cannabis Use Disorder	NIH	National Institute on Drug Abuse	2022 to 2023	$92,184	June 1, 2022	April 30, 2024	MARTIN, ERIN LINDSEY	reporter.nih.gov
Investigating the role of THC in mediating pain signaling in the BLA	NIH	National Institute on Drug Abuse	2024 to 2025	$91,934	August 1, 2024	July 31, 2027	ELLIOFF, KAYLIN	reporter.nih.gov
The Impact of Early Life Adversity on mGluR5-driven Endocannabinoid Signaling and Behavioral Adaptability	NIH	National Institute of Mental Health	2024 to 2025	$91,690	July 1, 2024	June 30, 2027	DE CARVALHO, GREGORY	reporter.nih.gov
Endocannabinoid regulation of the corticoaccumbens pathway and stress-enhanced cocaine-seeking behavior	NIH	National Institute on Drug Abuse	2023 to 2024	$91,456	August 9, 2023	August 8, 2026	GAULDEN, ANDREW	reporter.nih.gov
Modulation of pain hypersensitivity by terpenes via endocannabinoid release in descending circuits	NIH	National Center for Complementary & Integrative Health	2024 to 2025	$89,906	July 1, 2024	June 30, 2026	RICE, MYRA JANE	reporter.nih.gov
Effects of GABA Co-Release on Alcohol-Induced Synaptic Plasticity	NIH	National Institute on Alcohol Abuse and Alcoholism	2021 to 2022	$87,223	September 1, 2020	December 9, 2022	BLOODGOOD, DANIEL W	reporter.nih.gov
A Novel Animal Model to Investigate the Effects of Delta-9 - Tetrahydrocannabinol in the Primary Visual Cortex of Ferrets.	NIH	National Institute on Drug Abuse	2024 to 2025	$85,712	July 2, 2024	July 1, 2026	PRUITT, MOLLY ELIZABETH	reporter.nih.gov
Alcohol-Cannabinoid System Interactions in the Context of Pain and AUD	NIH	National Institute on Alcohol Abuse and Alcoholism	2024 to 2025	$82,218	August 1, 2024	July 31, 2028	LEE, STEPHANIE SUMIN	reporter.nih.gov
Sex Differences in Endocannabinoid Regulation of Behavioral Flexibility	NIH	National Institute on Drug Abuse	2023 to 2024	$81,062	January 13, 2023	December 23, 2024	STAPF, CATHERINE A.	reporter.nih.gov
Prenatal Cannabis: Effects on Developmental Milestones, Disinhibition, and Substance Initiation	NIH	National Institute on Drug Abuse	2024 to 2025	$74,616	July 1, 2024	June 30, 2026	IKEDA, AMI SALA	reporter.nih.gov
Sleep disruption in the progression and treatment of Alzheimer's disease	NIH	National Institute on Aging	2021 to 2022	$73,309	August 3, 2021	April 30, 2023	MARTIN, SHENEE	reporter.nih.gov
Regulation of Pain by Alcohol and Endocannabinoids in the Basolateral Amygdala	NIH	National Institute on Alcohol Abuse and Alcoholism	2021 to 2022	$73,262	August 20, 2020	May 31, 2023	CUCINELLO-RAGLAND, JESSICA	reporter.nih.gov
The role of Cannabinoid Receptor 2 in cerebrovascular protection following traumatic brain injury	NIH	National Institute of Neurological Disorders and Stroke	2023 to 2024	$71,254	February 1, 2023	December 31, 2025	BULLOCK, TRENT A	reporter.nih.gov
Annual Cannabinoid Research Society Symposium on the Cannabinoids	NIH	National Institute on Drug Abuse	2021 to 2025	$60,000	August 15, 2021	April 30, 2026	BRADSHAW, HEATHER BRYTE	reporter.nih.gov
Cannabis legalization and use during pregnancy: A Michigan Study	NIH	National Institute on Drug Abuse	2021	$53,855	July 15, 2021	December 31, 2022	VANDERZIEL, ALYSSA	reporter.nih.gov
Identification and modulation of insula to BNST circuit specific afferents in ethanol abstinence	NIH	National Institute on Alcohol Abuse and Alcoholism	2021	$50,773	April 8, 2021	June 30, 2022	LUCHSINGER, JOSEPH RICHARD	reporter.nih.gov
Impact of HIV and Cannabis Use on Executive Brain Function and Inflammation	NIH	National Institute on Drug Abuse	2025	$49,538	April 11, 2025	April 10, 2028	MCDONALD, KELLEN M	reporter.nih.gov
Endocannabinoid Modulation of the HIV-Induced Microglial Inflammatory Response	NIH	National Institute on Drug Abuse	2024	$48,974	June 17, 2024	June 16, 2025	ELLISON, ALYSHA	reporter.nih.gov
Endocannabinoid regulation of a septohabenular circuit in anxiety and depression	NIH	National Institute of Mental Health	2021	$46,730	September 1, 2017	June 30, 2022	VICKSTROM, CASEY R	reporter.nih.gov
The Ionotropic Cannabinoid Receptor TRPV1	NIH	National Institute on Drug Abuse	2021 to 2022	$44,079	July 1, 2021	August 9, 2022	MULLER, CHANTÉ	reporter.nih.gov
Endocannabinoid regulation of ventral hippocampus-nucleus accumbens circuit and consequences for stress-mediated behaviors	NIH	National Institute of Mental Health	2022 to 2023	$43,182	February 1, 2022	May 12, 2023	KONDEV, VERONIKA	reporter.nih.gov
Role of Endocannabinoid System in Seizure Sensitivity in Eclampsia	NIH	National Institute of Neurological Disorders and Stroke	2022	$41,352	July 1, 2022	June 30, 2023	JONES-MUHAMMAD, MARIA AISHA	reporter.nih.gov
The role L-type calcium channels (LTCCs) in regulating dopaminergic activity during cocaine abstinence	NIH	National Institute of Neurological Disorders and Stroke	2021	$39,995	July 1, 2019	January 31, 2022	AL-MUHTASIB, NOUR	reporter.nih.gov
Assessing Targeted Cannabinoid Therapeutic Potential Against HIV-1 Associated Neuronal Hyperexcitability and Neuroinflammation	NIH	National Institute on Drug Abuse	2022	$37,842	May 15, 2022	May 14, 2023	LEAGUE, ALEXIS	reporter.nih.gov
The Role of Amygdalar Endocannabinoids in Alcohol Drinking after Traumatic Brain Injury (TBI)	NIH	National Institute on Alcohol Abuse and Alcoholism	2021	$36,030	July 1, 2018	May 19, 2022	STIELPER, ZACHARY	reporter.nih.gov
The influence of aerobic exercise on consolidation of fear extinction learning in PTSD	NIH	National Institute of Mental Health	2023	$35,929	March 3, 2023	August 15, 2023	CROMBIE, KEVIN M	reporter.nih.gov
The role of Cannabinoid Receptor-1 in modulating addiction vulnerability	NIH	National Institute on Drug Abuse	2021	$32,136	April 6, 2020	December 31, 2021	BACHARACH, SAMUEL Z.	reporter.nih.gov
Mechanisms and treatment of pain-depressed behavior	NIH	National Institute on Drug Abuse	2021	$31,366	August 25, 2020	May 2, 2022	DIESTER, CLARE	reporter.nih.gov
Biochemical Mechanism of Eicosanoid Synthesizing Enzymes	NIH	National Institute of General Medical Sciences	2022	$29,977	April 1, 2017	July 31, 2022	DAS, ADITI	reporter.nih.gov
Novel PET Tracers for Imaging Monoacylglycerol Lipase in Endocannabinoid Signaling	NIH	National Institute on Drug Abuse	2021	$17,526	July 1, 2017	June 30, 2022	LIANG, STEVEN H	reporter.nih.gov
Feedback regulation of cannabinoid receptor trafficking and signaling	NIH	National Institute on Drug Abuse	2022	$17,148	February 1, 2022	April 30, 2022	LOTT, JOSHUA	reporter.nih.gov
2019 Cannabinoid Function in the CNS GRC & GRS	NIH	National Institute on Drug Abuse	2021	$10,000	April 1, 2019	March 31, 2022	PATEL, SACHIN	reporter.nih.gov
2023 Cannabinoid Function in the CNS Gordon Research Conference and Gordon Research Seminar	NIH	National Institute on Drug Abuse	2023	$10,000	April 1, 2023	March 31, 2024	HILLARD, CECILIA J	reporter.nih.gov
2025 Cannabinoid Function in the CNS Gordon Research Conference and Gordon Research Seminar	NIH	National Institute on Drug Abuse	2025	$10,000	August 1, 2025	July 31, 2026	HILLARD, CECILIA J	reporter.nih.gov
Cannabinoid type 2 receptors as a therapeutic target for substance use disorders	NIH	National Institute on Drug Abuse	2023	$8,368	February 1, 2023	February 20, 2023	CAREY IV, LAWRENCE MICHAEL	reporter.nih.gov
Imaging Alterations in Endocannabinoid Metabolism in Clinical High Risk and First Episode Psychosis	NIH	National Institute of Mental Health	2022	$1	September 20, 2017	June 2, 2022	MIZRAHI, ROMINA	reporter.nih.gov
Target Engagement and Clinical Symptom Change with a FAAH Inhibitor for Posttraumatic Stress Disorder	NIH	National Institute of Mental Health	2022	$1	September 5, 2022	December 14, 2022	STEIN, MURRAY B.	reporter.nih.gov

Organizations

Organization	Place	NIH awards	NIH amount	NSF amount
University of California, San Diego	La Jolla, CA	8	$17.3 million	$0
University of Colorado Denver	Aurora, CO	4	$12.2 million	$0
Medical College of Wisconsin	Milwaukee, WI	9	$9.1 million	$0
University of Maryland Baltimore	Baltimore, MD	10	$8.9 million	$0
Univ of North Carolina Chapel Hill	Chapel Hill, NC	9	$8.2 million	$0
Northeastern University	Boston, MA	4	$7.6 million	$0
Columbia University Health Sciences	New York, NY	3	$7.2 million	$0
Northwestern University at Chicago	Chicago, IL	4	$7.1 million	$0
University of Texas HLTH Science Center	San Antonio, TX	6	$6.7 million	$0
University of Minnesota	Minneapolis, MN	3	$5.8 million	$0
University of Pittsburgh at Pittsburgh	Pittsburgh, PA	5	$5.8 million	$0
Yale University	New Haven, CT	5	$5.5 million	$0
Research Triangle Institute	Research Triangle Park, NC	4	$5.4 million	$0
Scripps Research Institute, the	La Jolla, CA	5	$4.9 million	$0
University of California, San Francisco	San Francisco, CA	3	$4.9 million	$0
Vanderbilt University Medical Center	Nashville, TN	5	$4.7 million	$0
Temple Univ of the Commonwealth	Philadelphia, PA	3	$4.7 million	$0
Oregon Health & Science University	Portland, OR	6	$4.7 million	$0
Stanford University	Stanford, CA	6	$4.7 million	$0
University of Arizona	Tucson, AZ	3	$4.3 million	$0
University of Wisconsin-Milwaukee	Milwaukee, WI	2	$4.2 million	$0
LSU Health Sciences Center	New Orleans, LA	9	$4 million	$0
Wake Forest University Health Sciences	Winston-Salem, NC	2	$3.9 million	$0
SUNY at Buffalo	Amherst, NY	2	$3.8 million	$0
Johns Hopkins University	Baltimore, MD	5	$3.8 million	$0
SUNY at Stony Brook	Stony Brook, NY	3	$3.6 million	$0
Washington University	Saint Louis, MO	2	$3.4 million	$0
University of California-Berkeley	Berkeley, CA	2	$3.3 million	$0
Texas Biomedical Research Institute	San Antonio, TX	1	$3.3 million	$0
Queen's Medical Center	Honolulu, HI	1	$3.2 million	$0
Brown University	Providence, RI	1	$2.7 million	$0
Wayne State University	Detroit, MI	2	$2.7 million	$0
Washington State University	Pullman, WA	3	$2.7 million	$0
Miriam Hospital	Providence, RI	2	$2.6 million	$0
Abalone Bio, Inc.	Emeryville, CA	3	$2.6 million	$0
University of Washington	Seattle, WA	8	$2.6 million	$0
University of Tennessee Health Sci CTR	Memphis, TN	1	$2.5 million	$0
Indiana University	Bloomington, IN	3	$2.5 million	$0
University of Wisconsin-Madison	Madison, WI	1	$2.3 million	$0
Rutgers University New Brunswick	New Brunswick, NJ	2	$2.3 million	$0
University of Cincinnati	Cincinnati, OH	3	$2.3 million	$0
Icahn School of Medicine at Mount Sinai	New York, NY	2	$2.3 million	$0
University of Connecticut SCH of Med/dnt	Farmington, CT	1	$2.1 million	$0
Duke University	Durham, NC	1	$2 million	$0
Cincinnati Childrens Hosp Med CTR	Cincinnati, OH	1	$1.9 million	$0
Ohio State University	Columbus, OH	1	$1.9 million	$0
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC	New York, NY	2	$1.9 million	$0
Florida International University	Miami, FL	1	$1.8 million	$0
Univ of Massachusetts Med SCH Worcester	Worcester, MA	2	$1.8 million	$0
Michigan State University	East Lansing, MI	2	$1.8 million	$0
Albert Einstein College of Medicine	Bronx, NY	1	$1.6 million	$0
Augusta University	Augusta, GA	1	$1.4 million	$0
University of Massachusetts Amherst	Amherst, MA	1	$1.3 million	$0
University of Texas at Austin	Austin, TX	3	$1.3 million	$0
Weill Medical Coll of Cornell Univ	New York, NY	1	$1.2 million	$0
University of South Carolina at Columbia	Columbia, SC	1	$1.1 million	$0
Centre de Recherche de L'hopital Douglas	Montreal	1	$1.1 million	$0
CUNY City College	New York, NY	1	$1 million	$0
ST. Louis College of Pharmacy	St. Louis, MO	1	$1 million	$0
University of California-Riverside	Riverside, CA	1	$1 million	$0
New York University	New York, NY	1	$985,276	$0
Makscientific, LLC	Burlington, MA	2	$947,743	$0
Artiam Bio Inc.	Cary, NC	3	$945,046	$0
University of California-Irvine	Irvine, CA	4	$899,346	$0
Emory University	Atlanta, GA	3	$871,578	$0
Mayo Clinic Rochester	Rochester, MN	1	$746,308	$0
Ut Southwestern Medical Center	Dallas, TX	1	$668,955	$0
Virginia Commonwealth University	Richmond, VA	3	$656,557	$0
Oklahoma State University	Stillwater, OK	1	$551,696	$0
University of Colorado at Boulder	Boulder, CO	2	$515,288	$0
University of Alabama Tuscaloosa	Tuscaloosa, AL	1	$503,029	$0
University of New Mexico	Albuquerque, NM	1	$493,384	$0
Massachusetts General Hospital	Boston, MA	2	$491,026	$0
Old Dominion University	Norfolk, VA	1	$489,008	$0
North Carolina Central University	Durham, NC	1	$448,917	$0
University of Louisville	Louisville, KY	1	$445,262	$0
University of Connecticut	Storrs, CT	1	$442,750	$0
Creighton University	Omaha, NE	1	$440,924	$0
Mississippi State University	Mississippi State, MS	1	$436,465	$0
Eastern Virginia Medical School	Norfolk, VA	1	$432,598	$0
Elsohly Laboratories, Inc.	Oxford, MS	1	$427,879	$0
University of Kentucky	Lexington, KY	1	$420,750	$0
Iowa State University	Ames, IA	1	$404,264	$0
University of Virginia	Charlottesville, VA	1	$397,603	$0
Western Washington University	Bellingham, WA	1	$396,988	$0
Trinity University	San Antonio, TX	1	$371,023	$0
University of California-Santa Barbara	Santa Barbara, CA	1	$366,129	$0
Touro University of California	Vallejo, CA	1	$364,250	$0
California State University. East Bay Foundation, Inc.	Hayward, CA	1	$357,093	$0
Legacy Emanuel Hospital and Health Center	Portland, OR	1	$333,000	$0
Ramapo College of New Jersey	Mahwah, NJ	1	$328,000	$0
Zylo Therapeutics, Inc.	Greenville, SC	1	$293,749	$0
University of California Los Angeles	Los Angeles, CA	2	$286,781	$0
CSU Fullerton Auxiliary Services Corporation	Fullerton, CA	1	$284,000	$0
University of Puerto Rico at Aguadilla	Aguadilla, PR	1	$282,665	$0
Auburn University	Auburn, AL	1	$270,074	$0
University of Michigan at Ann Arbor	Ann Arbor, MI	2	$250,428	$0
Lovelace Biomedical & Environmental Research Institute	Albuquerque, NM	1	$249,000	$0
Lovelace Biomedical Research Institute	Albuquerque, NM	1	$245,741	$0
University of Alabama at Birmingham	Birmingham, AL	1	$225,792	$0

Funding by fiscal year

Fiscal year	NIH awards	NIH amount	NSF amount
2025	106	$46,775,187	$0
2024	116	$47,306,484	$0
2023	129	$60,171,286	$0
2022	132	$51,279,829	$0
2021	119	$48,115,985	$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunity	Number	Agency	Listing	Closes	Award ceiling	Why it matches
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)	PA-24-176	NIH		May 7, 2027	Not listed	Notice number printed on 1 award here
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)	PAR-24-089	NIH	93.279	November 13, 2026	$750,000	Same assistance listing 93.279 as 111 awards here
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)	PAR-25-370	NIH	93.279	November 16, 2026	$50,000	Same assistance listing 93.279 as 111 awards here
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)	PAR-25-369	NIH	93.279	November 18, 2026	Not listed	Same assistance listing 93.279 as 111 awards here
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)	PAR-25-371	NIH	93.279	November 18, 2026	Not listed	Same assistance listing 93.279 as 111 awards here
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)	PA-23-317	NIH	93.279	November 24, 2026	Not listed	Same assistance listing 93.279 as 111 awards here
Emerging Global Leader Award (K43 Independent Clinical Trial Required)	PAR-24-295	NIH	93.279	December 3, 2026	Not listed	Same assistance listing 93.279 as 111 awards here
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)	PAR-24-296	NIH	93.279	December 3, 2026	Not listed	Same assistance listing 93.279 as 111 awards here
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)	RFA-OD-24-011	NIH	93.279	December 4, 2026	Not listed	Same assistance listing 93.279 as 111 awards here
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)	PAR-27-039	NIH	93.279	January 5, 2027	Not listed	Same assistance listing 93.279 as 111 awards here
Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)	PAR-27-040	NIH	93.279	January 5, 2027	Not listed	Same assistance listing 93.279 as 111 awards here
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)	PAR-24-214	NIH	93.279	January 7, 2027	$375,000	Same assistance listing 93.279 as 111 awards here
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)	PAR-25-378	NIH	93.279	January 7, 2027	Not listed	Same assistance listing 93.279 as 111 awards here
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)	PAR-25-379	NIH	93.279	January 7, 2027	Not listed	Same assistance listing 93.279 as 111 awards here
HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)	RFA-DA-28-011	NIH	93.279	January 26, 2027	Not listed	Same assistance listing 93.279 as 111 awards here
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)	RFA-DA-28-012	NIH	93.279	January 26, 2027	Not listed	Same assistance listing 93.279 as 111 awards here
Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)	PAR-24-268	NIH	93.279	January 27, 2027	$500,000	Same assistance listing 93.279 as 111 awards here
BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)	RFA-NS-24-031	NIH	93.279	January 28, 2027	$750,000	Same assistance listing 93.279 as 111 awards here
Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)	RFA-DA-28-013	NIH	93.279	February 8, 2027	Not listed	Same assistance listing 93.279 as 111 awards here
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)	RFA-MH-26-170	NIH	93.279	February 8, 2027	Not listed	Same assistance listing 93.279 as 111 awards here

Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.